Our implementation leverages the <model>ResNet-152-Pathology</model> architecture, a specialized convolutional neural network adapted for histopathological image analysis with <params>60.2 million parameters</params>. The model incorporates residual connections and attention mechanisms specifically designed for high-resolution medical imaging tasks. Training was conducted using a distributed setup across <gpu_count>32</gpu_count> <hardware>NVIDIA A100 40GB GPUs</hardware> with synchronized batch normalization and mixed-precision training to optimize memory utilization. The dataset comprised 847,000 whole slide images from multiple cancer types, preprocessed into 224Ã—224 pixel patches with data augmentation including rotation, color jittering, and elastic deformation. We employed the AdamW optimizer with a learning rate schedule starting at 1e-3 with cosine annealing, weight decay of 0.01, and a batch size of 2048 distributed across all GPUs. Training convergence was achieved after <training>4 weeks</training> of continuous computation at our research facility in <country>Singapore</country>. The model underwent extensive validation using 5-fold cross-validation and was benchmarked against existing pathology classification models. Performance metrics included top-1 and top-5 accuracy, F1-scores for each cancer subtype, and area under the ROC curve. The final model was released in <year>2023</year> following comprehensive ablation studies and clinical validation with expert pathologists.